XI International Conference on Human Retrovirology: HTLV

第十一届人类逆转录病毒学国际会议：HTLV

• 批准号: 6559867
• 负责人: EDWARD L MURPHY
• 金额: $ 4.6万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-06-01 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6559867
• 关键词: Retroviridae; human T cell lymphotropic virus type 1; human T cell lymphotropic virus type 2; meeting /conference /symposium; travel

DESCRIPTION (provided by applicant): HTLV-I and HTLV-II are human retroviruses discovered just prior to HIV. They are important because they 1) infect up to 14 million (HTLV-I) and several million (HTLV-II) people worldwide; 2) cause hematologic, neurologic and autoimmune disease (HTLV-I) and neurologic disease together with increased susceptibility to bacterial infections (HTLV-II); and 3) serve as models for the epidemiology and pathogenesis of other human retroviral infections such as HIV. The International Conference on Human Retrovirology: HTLV and Related Viruses is a biennial conference which serves to unite the global community of HTLV researchers at the only regular international meeting devoted exclusively to HTLV infection. Three hundred to 350 scholars from HTLV-endemic regions and international infectious disease research institutions gather at this biennial meeting to present their latest data on the molecular virology, immunology, epidemiology and clinical outcomes of HTLV infection. Historically the meeting has been held in HTLV-endemic areas such as Hawaii, Jamaica, Trinidad, Brazil, and southeastern Japan, or at international research centers such as Paris and Dublin. The 2002 meeting planned for San Francisco will be the first USA meeting since 1994, and the organizers plan to emphasize research themes relevant to San Francisco and the USA, namely injection drug use-related HTLV-II and transfusion transmission viral infections. The San Francisco venue will allow more US junior scientists and students to attend due to lower domestic travel costs, fulfilling our goal of encouraging a new generation of HTLV researchers. In order to encourage the continued strong participation of attendees from developing countries with endemic HTLV infection, this grant application seeks to defray meeting expenses and keep registration fees affordable. The objectives for the XI Conference on Human Retrovirology: HTLV and related Viruses in San Francisco are: To provide a forum for the presentation of original research pertaining to HTLV-I, HTLV-II and related human and primate viruses; To promote interdisciplinary interaction between basic scientists, epidemiologists and clinical researchers toward fostering "bench to bedside" research; To promote interaction between scientists in the developed and developing world, and to stimulate international collaboration; and To expose students and young scientists to the HTLV research arena and promote their research careers.

描述（由申请人提供）：HTLV-I和HTLV-II是在HIV之前发现的人类逆转录病毒。 它们是重要的，因为它们1）感染全世界多达1400万（HTLV-I）和数百万（HTLV-II）人; 2）引起血液、神经和自身免疫疾病（HTLV-I）和神经疾病以及对细菌感染（HTLV-II）的易感性增加;和3）作为其他人逆转录病毒感染（如HIV）的流行病学和发病机制的模型。 人类逆转录病毒学国际会议：HTLV和相关病毒是一个两年一度的会议，旨在将全球HTLV研究人员团结在唯一一次专门讨论HTLV感染的定期国际会议上。 来自HTLV流行地区和国际传染病研究机构的300至350名学者聚集在这个两年一度的会议上，介绍他们关于HTLV感染的分子病毒学，免疫学，流行病学和临床结果的最新数据。 历史上，会议一直在HTLV流行地区举行，如夏威夷，牙买加，特立尼达，巴西和日本东南部，或在国际研究中心，如巴黎和都柏林。 计划于2002年在弗朗西斯科举行的会议将是自1994年以来第一次在美国举行的会议，组织者计划强调与弗朗西斯科和美国有关的研究主题，即与注射毒品有关的HTLV-II和输血传播病毒感染。 由于国内旅行费用较低，旧金山弗朗西斯科的场地将允许更多的美国初级科学家和学生参加，实现我们鼓励新一代HTLV研究人员的目标。 为了鼓励来自HTLV地方性感染的发展中国家的与会者继续积极参与，本赠款申请旨在支付会议费用并保持可负担的注册费。 在旧金山弗朗西斯科举行的第十一届人类逆转录病毒学会议：HTLV和相关病毒的目标是： 提供一个论坛，介绍有关HTLV-I、HTLV-II和相关人类和灵长类动物病毒的原始研究; 促进基础科学家、流行病学家和临床研究人员之间的跨学科互动，以促进“从实验室到临床”的研究; 促进发达国家和发展中国家科学家之间的互动，并促进国际合作; 让学生和年轻科学家接触HTLV研究竞技场，促进他们的研究事业。